Optimization of extracorporeal membrane oxygenation therapy using near‐infrared spectroscopy to assess changes in peripheral circulation: A pilot study

Hsiao‐Huang Chang,Yi‐Chih Chen,Chun‐Jung Huang,Chia‐Cheng Kuo,Yi‐Min Wang,Chia‐Wei Sun
DOI: https://doi.org/10.1002/jbio.202000116
IF: 3.3899
2020-08-12
Journal of Biophotonics
Abstract:<p>Near‐infrared spectroscopy (NIRS) has been proposed as a noninvasive modality for detecting complications in patients undergoing extracorporeal membrane oxygenation (ECMO), and it can simultaneously reveal the global circulatory status of these patients. We optimized ECMO therapy on the basis of real‐time peripheral NIRS probing. Three patients underwent venoarterial (VA) ECMO and one patient underwent venovenous (VV) ECMO. All patients received peripheral ECMO cannulation with routine distal perfusion catheter placement. We designed an experimental protocol to adjust ECMO blood flow over 1 h. Hemodynamic responses were measured using NIRS devices attached to the calf at approximately 60% of the distance from the ankle to the knee. HbO<sub>2</sub> levels change substantially with adjustments in ECMO flow, and they are more sensitive than HHb levels and the tissue saturation index (TSI) are. NIRS for optimizing ECMO therapy may be reliable for monitoring global circulatory status.</p><p>This article is protected by copyright. All rights reserved.</p>
optics,biochemical research methods,biophysics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to use near - infrared spectroscopy (NIRS) to monitor peripheral circulation changes in real - time during the treatment with extracorporeal membrane oxygenation (ECMO), in order to optimize the ECMO treatment plan. Specifically, the study aims to evaluate the effectiveness of NIRS as a non - invasive method in detecting complications in patients receiving ECMO treatment and to explore whether it can reliably reflect the patient's systemic circulation state. ### Research Background ECMO is a cardiopulmonary support technique for critically ill patients, which can stabilize hemodynamic status and respiratory failure. Although the application of ECMO has been significantly improved in the past 40 years, there are still many unresolved problems, such as severe, life - threatening complications, long - term intensive care unit (ICU) and hospital stays, and the cost - effectiveness of the technology. In addition, there is currently a lack of specific guidelines or reliable clinical parameters for adjusting ECMO treatment, resulting in different methods of ECMO setup and adjustment among different doctors and hospitals. ### Research Objectives This study aims to: 1. **Real - time Monitoring**: Provide a non - invasive method to monitor the patient's peripheral circulation changes in real - time by using NIRS technology to monitor the peripheral tissue oxygenation of patients receiving ECMO treatment. 2. **Optimize Treatment**: Precisely adjust the ECMO settings, including blood flow and the dosage of vasoactive drugs, according to the NIRS monitoring results. 3. **Reduce Complications**: Reduce the occurrence of complications and improve the patient's prognosis through more accurate treatment adjustment. ### Methods The research team designed an experimental protocol to observe the changes in tissue oxygenation in the lower limbs of patients by adjusting the blood flow of ECMO. The specific steps are as follows: - **Patient Selection**: Include patients receiving veno - arterial (VA - ECMO) and veno - venous (VV - ECMO) treatment. - **NIRS Monitoring**: Place probes on the patient's calves using the PortaLite system to monitor the changes in oxygenated hemoglobin (HbO₂), deoxygenated hemoglobin (HHb), and tissue saturation index (TSI). - **Data Collection and Analysis**: Record NIRS data under different ECMO blood flows and analyze the change trends of HbO₂, HHb, and TSI. ### Results Preliminary results show that the HbO₂ level changes significantly when adjusting the ECMO blood flow, while the changes in the HHb level and TSI are relatively small. The change in the HbO₂ level is more sensitive on the non - intubated side of the periphery than on the intubated side. These results indicate that NIRS can be used as an effective tool to optimize ECMO treatment and improve the overall circulation monitoring accuracy of patients. ### Discussion The NIRS technology performs well in monitoring peripheral circulation changes in ECMO patients, especially in monitoring the HbO₂ level. The study also found that the data of the same patient varies greatly on different measurement days, which may reflect the dynamic changes in the patient's clinical condition. Future research needs to further expand the sample size to verify these preliminary results and explore the potential of NIRS in broader clinical applications. ### Conclusion The NIRS technology has potential value in optimizing ECMO treatment and can monitor the patient's systemic circulation state in real - time and reliably. By precisely adjusting the ECMO settings, it is expected to improve the treatment effect, reduce complications, and improve the patient's prognosis.